Caldera, Synlogic Unite in $278M Biotech Merger
CAMBRIDGE, Mass., July 29, 2026 Synlogic, Inc. and Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement...
biotech financing
Advertisement
HanchorBio Expands Global Growth Strategy With Taiwan Listing and HCB101 Clinical Progress
TAIPEI, Taiwan, SHANGHAI, China and SAN FRANCISCO, California — May 28, 2026 HanchorBio, Inc. announced that the company will...
Apogee Therapeutics Lands $1.3B Blackstone Deal
SAN FRANCISCO and BOSTON, May 27, 2026 Apogee Therapeutics announced a landmark $1.3 billion strategic financing collaboration with Blackstone...
Turn Therapeutics Secures $25M for Skin Pipeline
LOS ANGELES, USA | March 24, 2026 Turn Therapeutics, Inc., a clinical-stage dermatology-focused biotechnology company, has announced a strategic...
Veraxa Biotech Advances SPAC Merger Plans
ZURICH, Switzerland – February 27, 2026 Veraxa Biotech AG announced that its shareholders have approved the previously disclosed business...
Advertisements
Jupiter Neurosciences Aligns Capital With Clinical Growth
JUPITER, Fla., Feb. 23, 2026 — Jupiter Neurosciences, a clinical-stage pharmaceutical company focused on neuroinflammation and central nervous system...
HCW Biologics Prices $1.5M Follow-On Offering
MIRAMAR, FLORIDA, UNITED STATES — February 17, 2026 HCW Biologics announced the pricing of a $1.5 million follow-on public...
Nektar Raises $460M to Advance Immunotherapy Pipeline
SAN FRANCISCO, Feb. 13, 2026 — Nektar Therapeutics announced the successful closing of a $460 million underwritten public offering,...
Veradermics Closes Full IPO Share Option Exercise
NEW HAVEN, Conn., Feb. 5, 2026 — Veradermics, Incorporated, a late clinical-stage biopharmaceutical company focused on dermatology therapeutics, announced...
TRexBio Secures $50M to Advance Precision Treg Therapies
SOUTH SAN FRANCISCO, CALIFORNIA | January 27, 2026 — TRexBio, Inc., a clinical-stage biotechnology company focused on precision immunoregulatory...
Advertisement
